Fewer patients met weight loss goals than reported Says primary and secondary trial goals still met Shares fall 11 percent. Sign up here. BOSTON, April 13 (Reuters) - Orexigen Therapeutics Inc said on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results